Document:

exv4wxcyx24y

Exhibit 4(c)(24)

ELAN CORPORATION, PLC Non-Executive Directors

Restricted Stock Unit Agreement

          THIS AGREEMENT, dated as of      , 200[ ], between Elan Corporation, plc (the
“Company”) and                     (the “Director” or “you”).

          WHEREAS, the Director has been granted the award set forth below under the Company’s 2006 Long
Term Incentive Plan (2009 Amendment and Restatement) (the “Plan”);

          NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, the
parties hereto agree that the following terms shall apply to the award.

               1. Award of Share Units. Pursuant to the provisions of the Plan, the terms of which
are incorporated herein by reference, the Director is hereby awarded ___Restricted
Stock Units (the “Restricted Stock Units”), subject to the terms and conditions herein set forth.
Capitalized terms used herein and not defined shall have the meanings set forth in the Plan. In
the event of any conflict between this Agreement and the Plan, the Plan shall control.

               2. Terms and Conditions. It is understood and agreed that the award of Restricted
Stock Units evidenced hereby is subject to the following terms and conditions:

                    (a) Vesting of Restricted Stock Units. Unless otherwise provided by the Company, all
amounts receivable in connection with any adjustments to the Shares under Section 3(c) of the Plan
shall be subject to the vesting schedule in this Section 2(a).

                    Except as otherwise provided in the Plan, all Restricted Stock Units will become vested (i) 90
days after you resign or are removed from the Board of Directors of the Company for any reason
other than Cause (as defined below), if you have served for a minimum of three years before such
resignation or removal; (ii) if you die while you are still a member of the Board of Directors of
the Company; (iii) if your membership on the Board of Directors of the Company terminates because
of your Total and Permanent Disability (as defined below) or (iv) on the tenth anniversary of the
date of this Agreement.

                    As used herein, “Cause” shall mean any of the following: (a) if a receiving order be made
against you or you make any arrangement or composition with your creditors generally; (b) if you
are prohibited from being a director by an order made under any provisions of the Company’s Acts or
(c) your commission of a material violation of any of the applicable personnel policies of the
Company.

 

- 2 -

                    As used herein “Total and Permanent Disability” means that you are unable to engage in any
substantial gainful activity by reason of any medically determinable physical or mental impairment
which can be expected to result in death or which has lasted, or can be expected to last, for a
continuous period of not less than one year.

                    (b) Distribution of Shares. At the time of vesting of the Restricted Stock Units, a
number of Shares equal to the number of Restricted Stock Units that become vested shall be
distributed to you, subject to tax withholding (if required), in a single sum distribution within
30 days following the date the Restricted Stock Units vest. You shall not be obliged to call for
delivery of the Shares, nor shall you forfeit your right to the Shares by not calling for delivery
of the Shares.

                    (c) Rights and Restrictions. The Restricted Stock Units shall not be transferable,
other than pursuant to will or the laws of descent and distribution. Prior to vesting of the
Restricted Stock Units and delivery of the Shares, you shall not have any rights or privileges of a
shareholder as to the Shares subject to the Restricted Stock Units. Specifically, you shall not
have the right to receive dividends or the right to vote such Shares prior to vesting of the
Restricted Stock Units and delivery of the Shares.

                    (d) Restrictions on Sale of Shares. By signing this Agreement, you agree not to sell
any Shares at a time when applicable laws or the Company’s policies prohibit a sale.

               3. Notices. Any notice required or permitted to be given under this Agreement shall
be in writing and shall be deemed to have been given when delivered personally or by courier, by
telegram, cablegram, facsimile message, electronic mail or telex message, or sent by certified or
registered mail, postage prepaid, return receipt requested, duly addressed to the party concerned
at the address indicated below or to such changed address as such party may subsequently by similar
process give notice of:

               If to the Company:

               Elan Corporation, plc

               Treasury Building

               Lower Grand Canal Street

               Dublin 2, Ireland

               Attn.: Company Secretary

 

- 3 -

               If to the Director:

               To the last address delivered to the Company by the
Director in the manner set forth herein.

               4. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of Ireland, without giving effect to principles of conflict of laws.

               5. Entire Agreement. This Agreement and the Plan constitute the entire agreement
among the parties relating to the subject matter hereof, and any previous agreement or
understanding among the parties with respect thereto is superseded by this Agreement and the Plan.
By signing this Agreement you agree to all of the terms and conditions described in this Agreement
and the Plan and you evidence your acceptance of the powers of the Committee of the Board of
Directors of the Company that administers the Plan.

               6. Section 409A. This Agreement is intended to be exempt from section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”) pursuant to the exemption available to
short-term deferrals, and shall be interpreted on a basis consistent with such intent. For
purposes of section 409A of the Code, each payment hereunder shall be treated as a separate
payment. In no event shall the Director, directly or indirectly, designate the calendar year of a
payment. The Plan and this Agreement may be amended in any respect deemed by the Company to be
necessary in order to preserve compliance with Section 409A of the Code or an exemption.

               7. Counterparts. This Agreement may be executed in two counterparts, each of which
shall constitute one and the same instrument.

          IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above
written.

	 	 	 	 	 
	 	ELAN CORPORATION, PLC

 	 
	 	By:  	 	 
	 	 	 
	 	Directorexv4wxcyx25y

Exhibit 4(c)(25)

EMPLOYMENT AGREEMENT

THIS AGREEMENT, dated as of this 21st day of November, 2008, (the “Effective Date”) by and among
ELAN PHARMACEUTICALS, INC., a Delaware corporation (the “Employer”), and ELAN CORPORATION,
PLC, an Irish public limited company (the “Parent”, together with the Employer, the
“Company”) and Dr. Carlos Paya (the “Executive”).

W I T N E S S E T H: 

WHEREAS, the Executive is willing to serve as the President of the Parent and the Employer desires
to retain the Executive in such capacity on the terms and conditions herein set forth; and

NOW, THEREFORE, in consideration of the promises and the mutual covenants herein contained, the
parties hereto hereby agree as follows:

          1. Employment and Duties.

          (a) General. The Company hereby employs the Executive as the President of the Parent, and the
Executive agrees upon the terms and conditions herein set forth to continue to be employed by the
Employer. In such capacity, the Executive shall report directly to the Chief Executive Officer of
the Parent (the “CEO”). The Executive shall perform all of the duties normally accorded to such
position, as directed by the Employer or the Parent, or as otherwise requested by the CEO. During
the Term, the Executive shall also serve as the senior executive officer of such other subsidiaries
of the Parent and the Employer as designated by the CEO or the Board of Directors of Parent (the
“Board”) and approved by the boards of directors of such subsidiaries.

          (b) Services. For so long as the Executive is employed by the Employer, the Executive shall
perform his duties faithfully and shall devote his full business time, attention and energies to
businesses of the Company, and while employed, shall not engage in any other business activity that
is in conflict with his duties and obligations to the Company.

          (c) No Other Employment. During the Term, the Executive shall not, directly or indirectly,
render services to any other person or organization for which he receives compensation; provided,
however, that upon the receipt of the Board’s prior written approval to be granted in its sole
discretion, which approval shall not unreasonably be withheld, the Executive may accept an election
to the board of directors of one other company without being deemed to have violated Section 1(b)
hereof, provided that such activities do not otherwise conflict with his duties and obligations to
the Company. No such approval will be required if the Executive seeks to perform services without
direct compensation therefore in connection with the management of personal investments or in
connection with the performance of charitable and civic activities, provided that such activities
do not contravene the provisions of Section 1(b) and Section 5 thereof.

 

          2. Term and Location of Employment.

          (a) Term. The term of the Executive’s employment under this Agreement (the “Term”)
shall commence on November 21, 2008 and shall continue until terminated pursuant to the provisions
of Section 4 hereof.

          (b) Location. As of the Effective Date, the Executive’s principal place of business shall be
the Company’s offices in San Francisco, California; however, the parties acknowledge that the
Executive shall be required to travel extensively in connection with the business of the Company.

          3. Compensation and Other Benefits. Subject to the provisions of this Agreement, the Employer
shall pay and provide the following compensation and other benefits to the Executive during the
Term as compensation for all services rendered hereunder:

          (a) Salary. The Employer shall pay to the Executive a base salary (the “Salary”) at an
initial annual rate of $600,000, payable to the Executive in accordance with the normal payroll
practices of the Employer as are in effect from time to time. The amount of the Executive’s Salary
shall be reviewed annually by the Employer in the same manner as other senior executives of the
Company, beginning in February, 2010.

          (b) Annual Bonus. The Executive shall be eligible to participate in the Company’s annual bonus
plan with a target award of 75% of Salary, performance based awards, and merit award plans as
determined by the Board (or a committee thereof) based upon a number of factors, including industry
competitiveness, Parent’s business strategy, and the degree to which company, individual, and/or
team goals are met.

          (c) Initial Option Grant. On December 1, 2008, the Parent shall grant the Executive an option
to purchase 300,000 shares of the Parent’s common stock (the “Stock”), with an exercise
price equal to the fair market value of the Stock on the date of grant and vesting in four equal
annual installments on the first, second, third, and fourth anniversary of the date of grant, and,
except as otherwise provided herein, having post-termination exercise periods and vesting
provisions following termination of employment that are no less favorable than those provided to
other senior executives of the Company (the “Initial Options”).

          (d) Subsequent Equity Grants. Effective January 1, 2010, the Executive shall be considered for
additional equity grants during the Term consistent with the Company’s annual equity grant
practices. The Board’s Leadership Development and Compensation Committee makes equity awards that
reflect the emphasis on differentiation and long-term focus that is an integral part of the
Company’s compensation practices and are designed to align Parent with its peers and be consistent
with industry best practices; factors that will affect the Executive’s future equity awards include
individual, team, group and company performance; and the Company’s business strategy and
competitive priorities.

-2-

 

          (e) Expenses. The Employer shall reimburse the Executive for all reasonable out-of-pocket
expenses incurred by the Executive in connection with his employment hereunder upon submission of
appropriate documentation or receipts in accordance with the policies and procedures of the
Employer as in effect from time to time. In addition, the Executive shall be eligible to receive
financial planning, and tax support and advice from the provider of his choice, at a reasonable and
customary annual cost.

          (f) Pension, Welfare and Fringe Benefits, etc. During the Term, the Executive shall be
eligible to participate in the pension, medical, disability and life insurance and other plans and
programs applicable to senior executives of the Employer generally in accordance with the terms of
such plans and programs as in effect from time to time. The foregoing shall not be construed to
limit the ability of the Company, the Employer or any of its affiliates to amend, modify or
terminate any such benefit plans, policies or programs at any time and from time to time.

(h) Sign-on Payments. On or about February 27, 2009 (consistent with timing of the Employer’s
payment of annual bonuses), the Employer shall pay the Executive $650,000, subject to typical
income and employment tax withholdings. If the Executive executes this Agreement on or prior to
November 19, 2008, the Employer shall pay the Executive an additional $150,000, subject to typical
income and employment tax withholdings, on or about November 26, 2008; provided, however, that the
Executive shall repay this amount to the Employer within 10 days of any voluntary termination of
employment or involuntary termination for “Cause” (as defined below) on or prior to November 20,
2009.

(i) Relocation. The Executive agrees to relocate his family to the San Francisco, California
area on or before September 1, 2009. In light of that relocation, the Executive shall be entitled
to the relocation program outlined on Exhibit A hereto.

          4. Termination of Employment. Subject to the notice and other provisions of this Section 4,
the Employer shall have the right to terminate the Executive’s employment hereunder, and the
Executive shall have the right to resign, at any time for any reason or for no stated reason.

          (a) Termination for Cause; Resignation Without Good Reason.

               (i) If the Executive’s employment is terminated by the Employer for “Cause” (as defined below)
or if the Executive resigns from his employment hereunder other than for “Good Reason” (as defined
below), the Executive shall be entitled to the following amounts: (A) payment of his Salary accrued
up to and including the date of termination or resignation, (B) payment in lieu of any accrued but
unused vacation time, and (C) payment of any unreimbursed expenses (collectively, the “Accrued
Obligations”). Except to the extent required by the terms of the programs described in Section
3(f) or applicable law, the Executive shall have no further right under this Agreement or otherwise
to receive any other compensation

-3-

 

               or to participate in any other plan, program or arrangement after such termination or
resignation of employment.

               (ii) “Cause” means that the Executive has (A) committed any act of willful misconduct,
including fraud, in connection with his employment by the Company; (B) materially breached any
provision of the Agreement; (C) failed, refused or neglected, other than by reason of a Disability
(as defined below), to timely perform any material duty or obligation under the Agreement or to
comply with any lawful directive of the Board; (D) been formally indicted for a crime involving
moral turpitude, dishonesty, fraud or unethical business conduct; or (E) been determined by a
governmental body or other appropriate authority to have violated any material law or regulation
that is applicable to the Company’s businesses. Upon a cure of the acts set forth in subsections
(B) and (C) by the Executive within the 20 business day cure period to the reasonable satisfaction
of the Board, such event shall no longer constitute Cause for purposes of this Agreement.

               (iii) “Good Reason” means (A) a breach by the Company of a material obligation under the
Agreement, including, without limitation, a material diminution in the Executive’s title, duties,
responsibilities or authority, (B) a material reduction in the Executive’s annual cash compensation
(other than by reason of the failure to achieve financial or other goals assigned by the Board) and
other than in connection with a general reduction in the compensation of executives of the Company
generally, or (C) the requirement that the Executive move his principal place of business by more
than 30 miles from that previously the case without his consent. The Executive must give the
Employer written notice within 90 days of the event that would give rise to “Good Reason” and
provide the Company with 30 days to cure. Upon a cure of the act so brought to the Company’s
attention such event shall no longer constitute Good Reason for purposes of this Agreement.

               (iv) Termination of the Executive’s employment for Cause shall be communicated by delivery to
the Executive of a written notice from the Employer stating that the Executive will be terminated
for Cause, specifying the particulars thereof and the effective date of such termination. The date
of a resignation by the Executive shall be the date specified in a written notice of resignation
from the Executive to the Employer; provided, however, that the Executive shall
provide at least 30 days’ advance written notice of resignation.

          (b) Involuntary Termination.

               (i) If the Employer terminates the Executive’s employment for any reason other than Disability
or Cause or the Executive resigns from his employment hereunder for Good Reason (such a resignation
or termination being hereinafter referred to as an “Involuntary Termination”), the
Executive shall be entitled to payment of the Accrued Obligations. In addition, in the event of the
Executive’s Involuntary Termination and execution and non-revocation of a release of all claims
against in the Company in the form then customarily prescribed by the Company, the Executive shall
be entitled to the following benefits:

-4-

 

          (A) a lump sum equal to 36 weeks of Salary plus two additional weeks of Salary
for each year of service, limited to a maximum period of 78 weeks of Salary (the
length of such period call the “Severance Period”);

          (B) all of the outstanding Initial Options granted to the Executive, and any
subsequent awards of options, shall immediately accelerate and remain outstanding
for two years following the Involuntary Termination or, if shorter, the balance of
the original term;

(C) for the length of the Severance Period or until the Executive obtains other employment, if
sooner, the Executive shall continue to be eligible to participate in the Company’s health plan (or
successor thereto, but excluding participation in any long-term disability plan) for himself and,
if then applicable, his eligible dependents, as the same may be changed from time to time for
employees of the Employer generally, as if the Executive had continued in employment during the
Severance Period but paying the full (employer and employee share) cost of the coverage. Such
payments shall be made within the time period that employees are required to pay to the Employer
for similar coverage. The Executive’s failure to pay the applicable costs shall result in the
cessation of the applicable coverage. The COBRA continuation coverage period under section 4980B of
the Internal Revenue Code of 1986, as amended (the “Code”) shall run concurrently. During the
Severance Period, the Company shall pay the Participant a monthly payment, on the first payroll
date of each month, equal to the COBRA cost of continued health and dental coverage under health
plan, as determined pursuant to section 4980B of the Code, less the amount that the Executive would
be required to contribute for health coverage if an active employee. These payments will commence
on the Company’s first payroll date after the Termination Date and will continue until the end of
the Severance Period or the earlier date of the cessation of coverage as provided above. The
Company shall also pay the Executive an additional amount which, after reduction for applicable
income and employment taxes owed with respect to such additional amount, equals the income and
employment taxes payable with respect to the monthly amount described herein.

               (ii) Payment of the amounts described in subsection (i) above shall be made as soon as
administratively practicable following the 30 days after the Executive’s Involuntary Termination
provided that no amounts shall be paid or due hereunder unless the Executive has executed and not
revoked the release described above. In the event of the Executive’s death subsequent to his
Involuntary Termination, but before the payments or commencement of benefits, payments and benefits
shall be paid to the Executive’s Beneficiary (as hereinafter defined) as soon as administratively
practicable.

          (c) Involuntary Termination in Connection with Certain Changes in Control.

-5-

 

               (i) If (A) the Parent undergoes a “Change in Control” (as defined below), (B) the Executive’s
employment is thereafter terminated within 12 months of the Change in Control under circumstances
that would constitute an Involuntary Termination and (C) the Executive executes, and does not
revoke, a release of all claims against in the Company in the form then customarily prescribed by
the Company, the Executive shall be entitled to the following benefits in lieu of any benefits
under Subsection (b) above:

          (I) the Accrued Obligations;

(II) a lump sum equal to three times the sum of the Executive’s Salary and the annual bonus for the
most recent completed year of service, determined as of the Executive’s termination date;

          (III) all of the outstanding Initial Options granted to the Executive shall
immediately accelerate and remain outstanding for two years following the
Involuntary Termination or, if shorter, the balance of the original term (subject
to cash out if the agreement pursuant to which the Change in Control is consummated
so provides);

          (IV) the benefits and reimbursements provided under (b)(i)(C) above for a
period of three years following the Executive’s Involuntary Termination or until
the Executive obtains other employment.

               (ii) “Change in Control” means (A) the consummation of a merger or consolidation of
the Parent with or into another entity or any other corporate reorganization (including without
limitation, the acquisition by any person of a majority of the voting shares in the Parent), if
more than 50% of the combined voting power of the continuing or surviving entity’s issued shares or
securities outstanding immediately after such merger, consolidation or other reorganization is held
by persons who were not shareholders of the Parent immediately prior to such merger, consolidation
or other reorganization; (B) the sale, transfer or other disposition of all or substantially all of
the Parent’s assets; (C) individuals who on the date of this Agreement constitute the Board (the
“Incumbent Directors”) cease for any reason, including, without limitation, as a result of
a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of
the Board, provided, however, that any individuals who becomes a director of the Company subsequent
to the date of this Agreement shall be considered an Incumbent Director if such person’s election
or nomination for election was approved by a vote of at least a majority of the Incumbent
Directors; but, provided further that any such person whose initial assumption of office is
in connection with an actual or threatened election contest relating to the election of members of
the Board or other actual or threatened solicitation of proxies or consents by or on behalf of a
person other than the Board, including by reason of agreement intended to avoid or settle any such
actual or threatened contest or solicitation, shall not be considered an Incumbent Director; or (D)
any transaction as a result of which any person becomes the “beneficial owner” (as defined in Rule
13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), directly
or indirectly, of securities of the Parent

-6-

 

               representing at least 50% of the total voting power represented by the Parent’s then
outstanding voting securities (e.g., issued shares). The term “person” shall have the same meaning
as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a trustee or
other fiduciary holding securities under an employee benefit plan of the Parent or of any
subsidiary of the Parent and (ii) a company owned directly or indirectly by the shareholders of the
Parent in substantially the same proportions as their ownership of the ordinary shares of the
Parent.

               (iii) Payment of the amounts described in subsection (i) above shall be made [begin] as soon
as administratively practicable following the 30 days after the Executive’s Involuntary Termination
provided that no amounts shall be paid or due hereunder unless the Executive has executed and not
revoked the release described above. In the event of the Executive’s death subsequent to his
Involuntary Termination, but before the payments or commencement of benefits, payments and benefits
shall be paid to the Executive’s Beneficiary (as hereinafter defined) as soon as administratively
practicable.

          (d) Termination Due to Disability. In the event of the Executive’s Disability, the Employer
shall be entitled to terminate his employment. In the case that the Employer terminates the
Executive’s employment due to Disability, the Executive shall be entitled to payment of (i) the
Accrued Obligations, and (ii) any disability benefits that are provided under the terms of any
plan, program or arrangement referred to in Section 3(f) applicable to the Executive at the time of
his Disability. “Disability” shall mean a physical or mental impairment that substantially
prevents him from performing his duties hereunder and that has continued for either (i) 180
consecutive days or (ii) any 180 days within a consecutive 360 day period. Any dispute as to
whether or not the Executive is disabled within the meaning of the preceding sentence shall be
resolved by a physician reasonably satisfactory to the Executive and the Employer, and the
determination of such physician shall be final and binding upon both the Executive and the
Employer.

          (e) Death. Except as provided in Sections 4(b)(ii), 4(c)(iii) and this Section 4(e), no Salary
or benefits shall be payable under this Agreement following the date of the Executive’s death. In
the event of the Executive’s death, the Accrued Obligations shall be paid to the Executive’s
Beneficiary within 30 days of such termination. The Executive’s Beneficiary shall also be entitled
to any death benefits that are provided under the terms of any plan, program or arrangement
referred to in Section 3(f) applicable to the Executive at the time of death.

          (f) Beneficiary. For purposes of this Agreement, “Beneficiary” shall mean the person or
persons designated in writing by the Executive to receive benefits under a plan, program,
arrangement or this Agreement, if any, in the event of the Executive’s death, or, if no such person
or persons are designated by the Executive, the Executive’s estate. No Beneficiary designation
shall be effective unless it is in writing and received by the Employer prior to the date of the
Executive’s death.

-7-

 

          5. Protection of the Employer’s Interests.

          (a) No Interference. For so long as the Executive is employed by the Employer and for one year
following his termination of employment for any reason (such period being referred to hereinafter
as the “Restricted Period”), the Executive shall not, either himself or through any agent,
whether for his own account or for the account of any other individual, partnership, firm,
corporation or other business organization (other than the Company or its affiliates),
intentionally solicit, endeavor to entice away from the Company, or otherwise interfere with the
relationship of the Company with, any individual who is employed by or otherwise engaged to perform
services for the Company (other than those individuals who are personally recruited by the
Executive) or any person or entity who is, or was within the then most recent twelve-month period,
a customer or client of the Company or its affiliates.

          (b) Secrecy. As a condition of his employment, the Executive shall be required to execute the
Company’s standard proprietary inventions and confidentiality agreement. In addition, the Executive
recognizes that the services to be performed by him hereunder are special, unique and extraordinary
in that, by reason of his employment hereunder, he may acquire confidential information and trade
secrets concerning the operation of the Company or its affiliates or subsidiaries, the use or
disclosure of which could cause the Company or its affiliates or subsidiaries substantial losses
and damages which could not be readily calculated and for which no remedy at law would be adequate.
Accordingly, the Executive covenants and agrees that he will not at any time, except in performance
of his obligations hereunder or with the prior written consent of the Board, directly or indirectly
disclose to any person any secret or confidential information that he may learn or has learned by
reason of his association with the Company, or any of its predecessors, subsidiaries and
affiliates. The term “confidential information” means any information not previously disclosed or
otherwise available to the public or to the trade with respect to the Company’s, or any of its
predecessors’, affiliates’ or subsidiaries’, products, facilities and methods, trade secrets and
other intellectual property, systems, procedures, manuals, confidential reports, product price
lists, customer lists, financial information, business plans, prospects or opportunities.

          (c) Exclusive Property. The Executive confirms that all confidential information is and shall
remain the exclusive property of the Company, its affiliates and subsidiaries. All business
records, papers and documents kept or made by the Executive relating to the business of the
Company, its predecessors, affiliates and subsidiaries shall be and remain the property of the
Company. Upon the termination of his employment with the Company or upon the request of the Company
at any time, the Executive shall promptly deliver to the Company, and shall not without the consent
of the Board retain copies of, any written materials not made available to the public, or records
and documents made by the Executive or coming into his possession concerning the business or
affairs of the Company or any of its affiliates or subsidiaries.

          (d) Injunctive Relief. Without intending to limit the remedies available to the Company, the
Executive acknowledges that a breach of any of the covenants contained in this

-8-

 

          Section 5 may result in material irreparable injury to the Company or its affiliates or
subsidiaries for which there is no adequate remedy at law, that it will not be possible to measure
damages for such injuries precisely and that, in the event of such a breach or threat thereof, the
Company, its affiliates or subsidiaries, shall be entitled to obtain a temporary restraining order
and/or a preliminary or permanent injunction restraining the Executive from engaging in activities
prohibited by this Section 5 or such other relief as may be required to specifically enforce any of
the covenants in this Section 5.

          6. Indemnification. The Company agrees that (i) if the Executive is made a party, or is
threatened to be made a party, to any threatened or actual claim, action, suit or proceeding,
whether civil, criminal, administrative, investigative, appellate or other (each, a
“Proceeding”), including an action by or in the right of the Company, by reason of the fact
that he is or was a director, officer, employee, agent, manager, or representative of the Company
or is or was serving at the request of the Company as a director, officer, member, employee, agent,
manager, or representative of any subsidiary or affiliate of the Company, or of another
corporation, partnership, joint venture, trust or other enterprise, or (ii) if any claim, demand,
request, investigation, dispute, controversy, threat, discovery request or request for testimony or
information (each, a “Claim”) is made, or threatened to be made, that arises out of or
relates to the Executive’s service in any of the foregoing capacities, then the Executive shall be
indemnified and held harmless by the Company to the fullest extent legally permitted or authorized
by the Company’s certificate of incorporation, by-laws, Board resolutions or, if greater, by
applicable law, against any and all costs, expenses, liabilities and losses (including, without
limitation, attorney’s fees, judgments, interest, expenses of investigation, penalties, fines,
ERISA excise taxes or penalties and amounts paid or to be paid in settlement) incurred or suffered
by the Executive in connection therewith, and such indemnification shall continue as to the
Executive even if he has ceased to be a director, officer, member, employee, agent, manager, or
representative of the Company and shall inure to the benefit of the Executive’s heirs, executors
and administrators. Except to the extent prohibited by applicable law, the Company shall advance to
the Executive all costs and expenses incurred by him in connection with any such Proceeding or
Claim within 15 days after receiving written notice requesting such an advance. Such notice shall
include, to the extent required by applicable law, an undertaking by the Executive to repay the
amount advanced if he is ultimately determined not to be entitled to indemnification against such
costs and expenses. The Company agrees to maintain director’s and officer’s liability insurance
covering the Executive for services rendered to the Company and its subsidiaries and, if reasonably
available, its affiliates covering the Executive for his services as a director officer, member,
employee, agent, manager or representative of the Company or any of its subsidiaries and
affiliates, if applicable.

          7. No Mitigation or Offset. The Executive shall not be required to mitigate the amount of any
payment provided for herein by seeking other employment or otherwise, and any such payment will not
be reduced in the event such other employment is obtained.

          8. Attorneys’ Fees and Costs. In the event that any action or other proceeding is instituted
to enforce any right or obligation under this Agreement, the prevailing

-9-

 

          party shall be entitled to receive, in addition to any other relief granted, the costs of
enforcement of this Agreement, including reasonable attorneys’ fees and court costs; provided,
however, that following a Change in Control, the Company shall pay the Executive’s reasonable
attorneys’ fees and court costs if it is determined that the Executive brought an action in good
faith and with a bona fide position without regard to whether the Executive prevails.

          9. General Provisions.

(a) No Other Severance Benefits. Except as specifically set forth in this Agreement, the Executive
covenants and agrees that he shall not be entitled to any other form of severance benefits from the
Employer, including, without limitation, benefits otherwise payable under any of the Employer’s
regular severance plans or policies, in the event his employment ends for any reason and, except
with respect to obligations of the Employer expressly provided for herein, the Executive
unconditionally releases the Employer and its subsidiaries and affiliates, and their respective
directors, officers, employees and stockholders, or any of them, from any and all claims,
liabilities or obligations under any severance or termination arrangements of the Employer or any
of its subsidiaries or affiliates.

(b ) Tax Withholding. All amounts paid to Employee hereunder shall be subject to all applicable
federal, state and local wage withholding.

(c) Notices. Any notice hereunder by either party to the other shall be given in writing by
personal delivery, or certified mail, return receipt requested, or (if to the Employer) by telex or
facsimile, in any case delivered to the applicable address set forth below:

To the Employer: ELAN PHARMACEUTICALS, INC.

875 Third Avenue

3rd Floor

New York, NY 10022

Attn: Kathleen Martorano

With a copy to:

Morgan, Lewis & Bockius LLP

1701 Market Street

Philadelphia, PA

Attn: Robert J. Lichtenstein, Esq.

To the Executive: Dr. Carlos Paya

Indianapolis, IN 46234

or to such other persons or other addresses as either party may specify to the other in writing.

-10-

 

(d) Representation by the Executive. The Executive represents and warrants that his entering into
this Agreement does not, and that his performance under this Agreement will not, violate the
provisions of any agreement or instrument to which the Executive is a party or any decree, judgment
or order to which the Executive is subject, and that this Agreement constitutes a valid and binding
obligation of the Executive in accordance with its terms. Breach of this representation will render
all of the Employer’s obligations under this Agreement void ab initio.

(e) Assignment; Assumption of Agreement. No right, benefit or interest hereunder shall be subject
to assignment, encumbrance, charge, pledge, hypothecation or setoff by the Executive in respect of
any claim, debt, obligation or similar process. The Employer will require any successor (whether
direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of
the business or assets of the Employer to assume expressly and to agree to perform this Agreement
in the same manner and to the same extent that the Employer would be required to perform it if no
such succession had taken place.

(f) Amendment. No provision of this Agreement may be amended, modified, waived or discharged unless
such amendment, modification, waiver or discharge is agreed to in writing and signed by the
parties. No waiver by either party hereto at any time of any breach by the other party hereto of,
or compliance with, any condition or provision of this Agreement to be performed by such other
party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at
any prior or subsequent time.

(g) Severability. If any term or provision hereof is determined to be invalid or unenforceable in a
final court or arbitration proceeding, (i) the remaining terms and provisions hereof shall be
unimpaired and (ii) the invalid or unenforceable term or provision shall be deemed replaced by a
term or provision that is valid and enforceable and that comes closest to expressing the intention
of the invalid or unenforceable term or provision.

(h) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of
the State of New York (determined without regard to the choice of law provisions thereof), and the
parties consent to jurisdiction in the United States District Court for the Southern District of
New York.

(i) Entire Agreement. This Agreement contains the entire agreement of the Executive, the Employer
and any predecessors or affiliates thereof with respect to the subject matter hereof and all prior
agreements and term sheets are superseded hereby except as expressly provided herein.
Notwithstanding the foregoing, this Agreement shall not supersede or effect any of the stock option
grants to the Executive made prior to the date hereof.

(j) Counterparts. This Agreement may be executed by the parties hereto in counterparts, each of
which shall be deemed an original, but both such counterparts shall together constitute one and the
same document.

-11-

 

(k) Code Section 409A.

(i) Interpretation. Notwithstanding the other provisions hereof, this Agreement is intended
to comply with the requirements of Section 409A of the Code, to the extent applicable, and this
Agreement shall be interpreted to avoid any penalty sanctions under Section 409A of the Code.
Accordingly, all provisions herein, or incorporated by reference, shall be construed and
interpreted to comply with Section 409A of the Code and, if necessary, any such provision shall be
deemed amended to comply with Section 409A of the Code and regulations thereunder. If any payment
or benefit cannot be provided or made at the time specified herein without incurring sanctions
under Section 409A of the Code, then such benefit or payment shall be provided in full at the
earliest time thereafter when such sanctions will not be imposed. All payments to be made upon a
termination of employment under this Agreement may only be made upon a “separation from service”
under Section 409A of the Code. For purposes of Section 409A of the Code, each payment made under
this Agreement shall be treated as a separate payment and all installment payments shall be treated
as a separate payment. In no event may the Executive, directly or indirectly, designate the
calendar year of payment.

(ii) Payment Delay. To the maximum extent permitted under Section 409A of the Code, the
cash severance payments payable under this Agreement are intended to comply with the “short-term
deferral exception” under Treas. Reg. §1.409A-1(b)(4), and any remaining amount is intended to
comply with the “separation pay exception” under Treas. Reg. §1.409A-1(b)(9)(iii); provided,
however, any amount payable to the Executive during the six-month period following the Executive’s
termination date that does not qualify within either of the foregoing exceptions and is deemed as
deferred compensation subject to the requirements of Section 409A of the Code, then such amount
shall hereinafter be referred to as the “Excess Amount.” If at the time of the Executive’s
termination of employment, the Employer’s (or any entity required to be aggregated with the
Employer under Section 409A of the Code) stock is publicly-traded on an established securities
market or otherwise and the Executive is a “specified employee” (as defined in Section 409A of the
Code and determined in the sole discretion of the Employer (or any successor thereto) in accordance
with the Employer’s (or any successor thereto) “specified employee” determination policy), then the
Employer shall postpone the commencement of the payment of the portion of the Excess Amount that is
payable within the six-month period following the Executive’s termination date with the Employer
(or any successor thereto). The delayed Excess Amount shall be paid in a lump sum to the Executive
within 10 days following the date that is six months following the Executive’s termination date
with the Employer (or any successor thereto). If the Executive dies during such six-month period
and prior to the payment of the portion of the Excess Amount that is required to be delayed on
account of Section 409A of the Code, such Excess Amount shall be paid to the personal
representative of the Executive’s estate within sixty (60) days after the Executive’s death.

(iii) Reimbursements. All reimbursements provided under this Agreement shall be made or
provided in accordance with the requirements of Section 409A of

-12-

 

the Code, including, where applicable, the requirement that (A) any reimbursement is for expenses
incurred during the Executive’s lifetime (or during a shorter period of time specified in this
Agreement), (B) the amount of expenses eligible for reimbursement during a calendar year may not
affect the expenses eligible for reimbursement in any other calendar year, (C) the reimbursement of
an eligible expense will be made on or before the last day of the taxable year following the year
in which the expense is incurred, and (D) the right to reimbursement is not subject to liquidation
or exchange for another benefit. Any tax gross up payments to be made hereunder shall be made not
later than the end of the Executive’s taxable year next following the Executive’s taxable year in
which the related taxes are remitted to the taxing authority.

IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the day and year first
written above.

ELAN PHARMACEUTICALS, INC.

By: /s/ Kathleen Martorano

Name: Kathleen Martorano

Title: Executive Vice President

               Strategic Human Resources

ELAN CORPORATION PLC

By: /s/ Liam Daniel

Name: Liam Daniel

Title: EVP & Company Secretary

EXECUTIVE

/s/ Carlos Paya

Dr. Carlos Paya

 

 

EXHIBIT A

As of the effective date, the Executive’s principal place of business will be Elan’s offices in
South San Francisco, CA. The Executive’s family will not fully relocate to the greater San
Francisco area until summer 2009; before this period, the Employer will provide the Executive with
access to commercial flights and/or Company aircraft to travel to business locations from
Indianapolis, IN; the Company will also provide temporary housing for the Executive in the greater
San Francisco area; a highlight of the relocation benefits offered includes:

Prior to Summer 2009 

•  Temporary housing for the Executive, with the size and style also suitable to
accommodate the Executive’s wife and children on visits

•  Business travel from Indianapolis, IN, as required to perform job duties
(commercial and/or Company aircraft)

Summer 2009 

•  Incidental allowance, equal to two months salary, grossed up for taxes; to be
used for relocation expenses not specifically reimbursed by the relocation plan (e.g., new
furniture, utilities set-up)

•  Realtor and home sale in Indianapolis, IN; Elan will pay for standard seller’s
closing costs and normal and customary real estate commission

•  Home sale loss protection capped at a maximum of $50,000, unless the Chief
Executive Officer approves a higher amount in his discretion

•  Two home finding trips, used for the Executive and the family to visit the
greater San Francisco area to look at housing/schools

•  Realtor and home purchase/rental in greater San Francisco area

•  You are eligible for reimbursement of usual and customary closing costs
associated with the purchase of a home in the greater San Francisco area; the Executive must
purchase the new home within 12 months from the date the Executive and the Executive’s family fully
relocate to the greater San Francisco area

•  Mortgage subsidy program, which will provide the Executive assistance in
paying the Executive’s mortgage on a new home in the greater San Francisco area; specific amount to
be determined and will be based on property size, home-loan value, area and other factors. If the
Executive and family decide to rent long-term, in the San Francisco area, a portion of this benefit
will be used to subsidize the Executive’s rent and specific amount will be based on the factors
outlined in the last sentence

•  Household goods shipment and final move travel

•  Temporary storage and spousal career assistance, as needed

Summer 2010 

• 
The relocation model assumes that the Executive’s home in Indianapolis, IN is
sold prior to summer 2009 when the family’s move to the San Francisco area is complete. As
previously discussed, the Company acknowledges the potential that the Executive’s home may not
sell prior to this time; in this instance, the Company will pay for the Executive’s rent in
the San Francisco area, in full, through summer 2010 or until the home in Indianapolis, IN is
sold, whichever is sooner. Once the home is sold, the above discussed mortgage/rent subsidy
program will begin

Note: More details to be provided by Elan and Primacy, our relocation partner

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]